“Sativa seeks to invest in global companies which are well-placed to take advantage of the dynamic regulatory environment surrounding medical Cannabis. Our investment strategy focuses on production, pharmacology, testing and compliance, R&D commercialisation, and sales and marketing. The Directors are already engaging with possible target investments in their key areas of interest.”

Meet Our Team

A successful entrepreneur with a proven track record. Read more……


A qualified Chartered Accountant with significant commercial experience… Read more….

Angus Kerr
Angus Kerr
non-Executive Director

An adviser and capital markets professional with nearly 25 years’ experience in global banking Read more……


Mark Blower
Mark Blower
non-Executive Director

An experienced fund manager and corporate financier. Read more….

Jonathan Wearing
Jonathan Wearing

A corporate finance professional Read more….

“Sativa management are expertly supported by an independent advisory board. Investment policy and proposals will be approved by them.”

Advisory Board

Sir Breckenridge has a medical career as a pharmacologist that totals close to 60 years.  Read More

Dr. Peter Feldschreiber is dually qualified as a barrister and physician. Read More…

Dr. Ungar qualified in medicine, with additional qualifications in medical biochemistry at the Royal Free Hospital. Read More…



PeterHouse Capital

Financial PR

Abchurch Communications


Hill Dickinson


Wellbeck Associates